Scientists identify gene that may indicate predisposition to schizophrenia

In a new study from The American Journal of Human Genetics, a research team lead by Xinzhi Zhao and Ruqi Tang (Shanghai Jiao Tong University) present evidence that genetic variation may indicate predisposition to schizophrenia. Specifically, their findings identify the chitinase 3-like 1 gene as a potential schizophrenia-susceptibility gene and suggest that the genes involved in biological response to adverse conditions are likely linked to schizophrenia.

Analyzing two separate cohorts of Chinese patients with schizophrenia, the researchers observed a positive association between schizophrenia and genetic variations in the promoter region of the chitinase 3-like 1 (CHI3L1) gene, an association that was significant in both population-based and family-based investigations.

The CHI3L1 gene acts as a survival factor in response to adverse environments, countering various types of physiological stress, such as inflammation, nutrient deprivation, and oxygen deficiency, all of which may induce high expression of CHI3L1. The gene is located on chromosome 1q32.1, a region that has been previously shown to have a weak correlation to schizophrenia.

A number of environmental factors, including prenatal exposure to disease, have been reported as risk factors of schizophrenia. However, the researchers argue that sensitivity to environmental stressors varies widely among individuals, and "at least part of this variation may be genetic in origin and/or involve gene-environment factors," they write.

Genetic variations that change the expression of CHI3L1 can influence key processes dependent on CHI3L1 levels, knocking out portions of the AKT-mediated signal pathway. The AKT-mediated signal pathway has been shown to be impaired in patients with schizophrenia, and antipsychotic medication may induce AKT activation, to compensate for the impairment.

Additionally, activation of the inflammatory response has been observed in those with schizophrenia and other affective disorders.

"In conclusion, our findings identify CHI3L1 as a potential schizophrenia-susceptibility gene," write the authors. "Our results . . . support the proposal that genes involved in biological response to adverse environmental conditions play roles in the predisposition to schizophrenia."

Citation: Xinzhi Zhao, Ruqi Tang, et al., "Functional Variants in the Promoter Region of Chitinase 3–Like 1 (CHI3L1) and Susceptibility to Schizophrenia." The American Journal of Human Genetics, 2007;80:12-00018.

Source: University of Chicago

Related stories:

Researchers piece together gene 'network' linked to schizophrenia
Reporting this week in the Archives of General Psychiatry, researchers at the Johns Hopkins University School of Medicine have uncovered for the first time molecular circuitry associated with schizophrenia that links three previously known, yet unrelated proteins.
Human brains pay a price for being big
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
Memory, depression, insomnia -- and worms?
Researchers have spent decades probing the causes of depression, schizophrenia and insomnia in humans. But a new study may have uncovered key insights into the origins of these and other conditions by examining a most unlikely research subject: worms.
New schizophrenia genes uncovered
(PhysOrg.com) -- Researchers have discovered new genes linked to schizophrenia, it has been revealed. In two papers published in Nature today (July 30), scientists identify four mutated gene regions that may hold the key to producing new tailor-made drugs to treat the devastating mental illness.
Researchers find a partially shared genetic profile between schizophrenia and bipolar disorder
Both schizophrenia and bipolar disorder can be disabling conditions, and both present clinically with significant mood and psychotic symptoms. These two illnesses also share genetic variants that might be involved in the predisposition to both disorders. A new study scheduled for publication in the July 15th issue of Biological Psychiatry sought to analyze the patterns of gene expression in the brains of individuals diagnosed with one of these disorders to search for a common "characteristic [genetic] signature."
Protein on 'speed' linked to ADHD
A genetic change in the dopamine transporter – one of the brain's dopamine-handling proteins – makes it behave as if amphetamine is present and "run backward," Vanderbilt University Medical Center investigators report this week in The Journal of Neuroscience.
Sweat, luck and eureka: Recipes for scientific discovery
Every week thousands of academic articles heralding discoveries in medicine and science are vetted and validated before being published in no-nonsense journals with names such as "Acta Crystallographica," "Methods in Enzymology," or "Macromolecules".
The APCs of nerve cell function
Rapid information processing in the nervous system requires synapses, specialized contact sites between nerve cells and their targets. One particular synapse type, cholinergic, uses the chemical transmitter acetylcholine to communicate between nerve cells. Cholinergic synapses are essential for normal learning and memory, arousal, attention, and all autonomic (involuntary) nervous system functions. Malfunction of cholinergic synapses is implicated in Alzheimer's disease, age-related hearing loss, autonomic neuropathies, and certain forms of epilepsy and schizophrenia. Despite the importance of cholinergic synapses for cognitive and autonomic functions, little is known about the mechanisms that direct their assembly during development.

News discussion:

Medicine & Health news